Back to search
Prevention of Rejection in Kidney Transplant
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Prevention of Rejection in Kidney Transplant trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Prevention of Rejection in Kidney Transplant trials you may qualify forThe goal of this multi-national, multi-center, open-label, randomized Phase 2 trial is to determine the safety and efficacy of administering expanded regulatory…
This clinical trial investigates the transplantation of donor kidneys that have been genetically modified ex vivo using CRISPR-Cas9 genome editing to reduce imm…
This study will evaluate the safety, PK, and efficacy of AT 1501 in patients undergoing kidney transplantation.
Induction therapy by either T-cell depleting polyclonal antibodies such as anti-thymocyte globulins (ATG) or non-depleting anti-interleukine 2 receptor monoclon…
Primary Objectives: * Cohort A: To evaluate the efficacy of BIVV020 in prevention of AMR * Cohort B: To evaluate the efficacy of BIVV020 in treatment of active…
This is a phase 1 trial, 36 month duration for subjects with end-stage renal disease (ESRD). The objectives of the trail are1) Determine the safety of ECP-DL ce…